These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29478590)

  • 21. Dancing in the dark? The status of late-onset Alzheimer's disease genetics.
    Bertram L; Tanzi RE
    J Mol Neurosci; 2001 Oct; 17(2):127-36. PubMed ID: 11816786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants.
    Blauwendraat C; Wilke C; Jansen IE; Schulte C; Simón-Sánchez J; Metzger FG; Bender B; Gasser T; Maetzler W; Rizzu P; Heutink P; Synofzik M
    Neurobiol Aging; 2016 Jan; 37():208.e11-208.e17. PubMed ID: 26522186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel PSEN1 mutations (H214N and R220P) associated with familial Alzheimer's disease identified by targeted exome sequencing.
    Piccoli E; Rossi G; Rossi T; Pelliccioni G; D'Amato I; Tagliavini F; Di Fede G
    Neurobiol Aging; 2016 Apr; 40():192.e7-192.e11. PubMed ID: 26925509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial Alzheimer's Disease and Recessive Modifiers.
    Vélez JI; Lopera F; Silva CT; Villegas A; Espinosa LG; Vidal OM; Mastronardi CA; Arcos-Burgos M
    Mol Neurobiol; 2020 Feb; 57(2):1035-1043. PubMed ID: 31664702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide association studies in Alzheimer disease.
    Waring SC; Rosenberg RN
    Arch Neurol; 2008 Mar; 65(3):329-34. PubMed ID: 18332245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The current status of Alzheimer's disease genetics: what do we tell the patients?
    Bertram L; Tanzi RE
    Pharmacol Res; 2004 Oct; 50(4):385-96. PubMed ID: 15304236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.
    Sieczkowski E; Milenkovic I; Venkataramani V; Giera R; Ströbel T; Höftberger R; Liberski PP; Auff E; Wirths O; Bayer TA; Kovacs GG
    J Alzheimers Dis; 2015; 44(1):103-14. PubMed ID: 25182745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetics of Alzheimer's disease.
    Bertram L; Tanzi RE
    Prog Mol Biol Transl Sci; 2012; 107():79-100. PubMed ID: 22482448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of Alzheimer disease in the pre- and post-GWAS era.
    Ertekin-Taner N
    Alzheimers Res Ther; 2010 Mar; 2(1):3. PubMed ID: 20236449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide association studies in Alzheimer's disease: a review.
    Tosto G; Reitz C
    Curr Neurol Neurosci Rep; 2013 Oct; 13(10):381. PubMed ID: 23954969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene identification in Alzheimer's disease.
    Saunders AM
    Pharmacogenomics; 2001 Aug; 2(3):239-49. PubMed ID: 11535112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of early-onset Alzheimer dementia.
    Rademakers R; Cruts M; Van Broeckhoven C
    ScientificWorldJournal; 2003 Jun; 3():497-519. PubMed ID: 12847300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomics and Functional Genomics of Alzheimer's Disease.
    Kamboh MI
    Neurotherapeutics; 2022 Jan; 19(1):152-172. PubMed ID: 34935119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic architecture of Alzheimer's disease.
    Neuner SM; Tcw J; Goate AM
    Neurobiol Dis; 2020 Sep; 143():104976. PubMed ID: 32565066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetics of Alzheimer's disease: an update.
    Brouwers N; Sleegers K; Van Broeckhoven C
    Ann Med; 2008; 40(8):562-83. PubMed ID: 18608129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Emerging Therapeutic Targets Revealed by Genome Analysis in Alzheimer's Disease].
    Ikeuchi T
    Brain Nerve; 2017 Jul; 69(7):789-798. PubMed ID: 28739993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome scan on Swedish Alzheimer's disease families.
    Sillén A; Forsell C; Lilius L; Axelman K; Björk BF; Onkamo P; Kere J; Winblad B; Graff C
    Mol Psychiatry; 2006 Feb; 11(2):182-6. PubMed ID: 16288313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.